GSK has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
GlaxoSmithKline PLC's cash flow for dividends for the three months ended in Dec. 2014 was $-1,491 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Dec. 2014 was $-6,631 Mil.
Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.
GlaxoSmithKline PLC's quarterly payment of dividends declined from Jun. 2014 ($-1,860 Mil) to Sep. 2014 ($-1,769 Mil) and declined from Sep. 2014 ($-1,769 Mil) to Dec. 2014 ($-1,491 Mil).
GlaxoSmithKline PLC's annual payment of dividends increased from Dec. 2012 ($-6,162 Mil) to Dec. 2013 ($-6,412 Mil) but then declined from Dec. 2013 ($-6,412 Mil) to Dec. 2014 ($-6,335 Mil).
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.
GlaxoSmithKline PLC Cash Flow for Dividends for the trailing twelve months (TTM) ended in Dec. 2014 was -1511.62790698 (Mar. 2014 ) + -1859.56006768 (Jun. 2014 ) + -1768.72964169 (Sep. 2014 ) + -1491.39280125 (Dec. 2014 ) = $-6,631 Mil.
GlaxoSmithKline PLC Annual Data
GlaxoSmithKline PLC Quarterly Data